AGREEMENT FOR CONDUCTING THE CLINICAL STUDYAgreement for Conducting the Clinical Study • November 9th, 2020
First party, Mr./Ms. _____________________________________ (name of the legal representative of the SPONSOR), N.I.F. number _____, acting on behalf of _______________________________________ (full name of SPONSORING organization – pharmaceutical laboratory, scientific society, legal entity), (SPONSOR, from now on), domiciled at ______________________________ (full SPONSOR’S address) _______________ from (town and zip code), and C.I.F. number ______________, authorized as per power of attorney issued at ______________, dated ___________, and notarized by Mr./Ms. _________________ .
